J Physiol Wellcome Trust-funded researchers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 571, Number 1, 57-73, February 15, 2006 DOI: 10.1113/jphysiol.2005.100586
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
571/1/57    most recent
jphysiol.2005.100586v2
jphysiol.2005.100586v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Núñez, L.
Right arrow Articles by Villalobos, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Núñez, L.
Right arrow Articles by Villalobos, C.
Related Collections
Right arrow Cellular

Cellular

Cell proliferation depends on mitochondrial Ca2+ uptake: inhibition by salicylate

Lucía Núñez1, Ruth A. Valero1, Laura Senovilla1, Sara Sanz-Blasco1, Javier García-Sancho1 and Carlos Villalobos1

1 Instituto de Biología y Genética Molecular (IBGM), Universidad de Valladolid and CSIC, C/Sanz y Forés s/n. 47003-Valladolid, Spain

Store-operated Ca2+ entry (SOCE) is a ubiquitous Ca2+ influx pathway involved in control of multiple cellular and physiological processes including cell proliferation. Recent evidence has shown that SOCE depends critically on mitochondrial sinking of entering Ca2+ to avoid Ca2+-dependent inactivation. Thus, a role of mitochondria in control of cell proliferation could be anticipated. We show here that activation of SOCE induces cytosolic high [Ca2+] domains that are large enough to be sensed and avidly taken up by a pool of nearby mitochondria. Prevention of mitochondrial clearance of the entering Ca2+ inhibited both SOCE and cell proliferation in several cell types including Jurkat and human colon cancer cells. In addition, we find that therapeutic concentrations of salicylate, the major metabolite of aspirin, depolarize partially mitochondria and inhibit mitochondrial Ca2+ uptake, as revealed by mitochondrial Ca2+ measurements with targeted aequorins. This salicylate-induced inhibition of mitochondrial Ca2+ sinking prevented SOCE and impaired cell growth of Jurkat and human colon cancer cells. Finally, direct blockade of SOCE by the pyrazole derivative BTP-2 was sufficient to arrest cell growth. Taken together, our results reveal that cell proliferation depends critically on mitochondrial Ca2+ uptake and suggest that inhibition of tumour cell proliferation by salicylate may be due to interference with mitochondrial Ca2+ uptake, which is essential for sustaining SOCE. This novel mechanism may contribute to explaining the reported anti-proliferative and anti-tumoral actions of aspirin and dietary salicylates.

(Received 24 October 2005; accepted after revision 7 December 2005; first published online 8 December 2005)
Corresponding author C. Villalobos: Instituto de Biología y Genética Molecular (IBGM), c/Sanz y Forés s/n. 47003-Valladolid, Spain. Email: carlosv{at}ibgm.uva.es


L. Núñez and R.A. Valero contributed equally to this work.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
J. Roman, A. F. de Arriba, S. Barron, P. Michelena, M. Giral, M. Merlos, E. Bailon, M. Comalada, J. Galvez, A. Zarzuelo, et al.
UR-1505, a New Salicylate, Blocks T Cell Activation through Nuclear Factor of Activated T Cells
Mol. Pharmacol., August 1, 2007; 72(2): 269 - 279.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 The Physiological Society.